This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Mihalis Kariolis, Ph.D.
Scientist, Antibody and Protein Engineering at Denali Therapeutics


Mihalis is a Principal Scientist and Director of Antibody Discovery and Protein Engineering at Denali Therapeutics, where his work is focused on engineering brain-penetrant biotherapeutics for the treatment of neurodegenerative diseases. Mihalis completed his B.S. degree in Biomedical Engineering at Rensselaer Polytechnic Institute and his Ph.D. in Bioengineering at Stanford University in Dr. Jennifer Cochran's lab.

Agenda Sessions

  • Brain Delivery of Biotherapeutics Using An Engineered Fc Transport Vehicle